InvestorsHub Logo
Followers 4
Posts 549
Boards Moderated 0
Alias Born 04/11/2017

Re: None

Monday, 11/13/2017 11:25:01 PM

Monday, November 13, 2017 11:25:01 PM

Post# of 7747
For all you science guys out there who are smarter than me. If Aldox gets FDA approved, which (if I am not mistaken) is really just doxorubicin with an enhancement delivery method, I am wondering if it could lead to future fast tracked LADR approvals as opposed to the multitude of trials usually required. My thought is that CYTR is really just enhancing existing approved drugs via a new delivery method. If Aldox trials successfully prove the delivery method to be effective, could future LADR trials with existing approved chemotherapy drugs be fast tracked. Both the drug and delivery have already been proven effective. This would not include combo trials, just new drug applications. Just a thought and probably wishful thinking. Thanks!